Polio Case in New York Caused by “Vaccine-Derived” Poliovirus
Opinion | The first reported case of polio in the United States since 2013 was confirmed in New York last week. According to New York health officials, a young adult in Rockland County contracted type 2 “vaccine-derived” poliovirus (VDPV2), which may have been transmitted by someone who received the Sabin live attenuated oral polio vaccine (OPV). […]
How the Novavax Coronavirus Vaccine Uses Moth Cells
As companies like Moderna and Pfizer race to use cutting-edge mRNA technology to deliver the first set of coronavirus vaccines, Novavax took a different approach. The Maryland biotechnology company used insect cells to produce the coronavirus’s unique spiked protein, which can then be introduced to patients to prime their immune systems. This process is known […]
Model Misspecification and Grossly Inflated Estimates of Lives Saved
In a recent study published in The Lancet Infectious Diseases, Watson et al. apply mathematical modeling to estimate that mass COVID-19 vaccinations saved between 14-20 million lives worldwide during the first year of the COVID-19 vaccination program. Previous Brownstone [Institute] articles by Horst and Raman have already pointed out several erroneous assumptions in the study regarding infection- vs. vaccine-derived immunity duration […]
VAERS Data Reveal Serious Adverse Event Reports in Babies After mRNA COVID Shots
On June 15, 2022, the Vaccines and Related Biological Products Advisory Committee (VRBPAC) of the U.S. Food and Drug Administration (FDA) advised the FDA to grant an Emergency Use Authorization (EUA) for Moderna/NIAID and Pfizer/BioNTech’s mRNA COVID-19 biologics be given to infants and children under age five and as young as six months old. With […]
Research Confirms Menstrual Cycle Bleeding Changes After COVID Shot
Last week, University of Illinois researchers published a study funded by the National Institutes of Health (NIH) in the journal Science Advances on menstrual cycle bleeding changes after COVID shots. The study featured a web-based survey of almost 40,000 individuals and found 42 percent of those who were menstruating reported unexpected heavy bleeding after receiving […]
FDA Grants EUA for Novavax’s COVID Vaccine
Opinion | On July 13, 2022, the U.S. Food and Drug Administration (FDA) granted Emergency Use Authorization (EUA) to Novavax to distribute its experimental two-dose NVX-CoV2373 (also known as “Nuvaxovid” and “Covovax”) COVID-19 vaccine for use by adults. The decision was expected, given the favorable recommendation by the FDA’s Vaccines and Related Biological Products Advisory […]
